real-time news and commentary for investors
Wednesday, May 9
2012, 3:08 PM
St. Jude Medical (STJ +3.5%) trades up after the FDA approves its Ellipse implantable...
St. Jude Medical (STJ +3.5%) trades up after the FDA approves its Ellipse implantable cardioverter defibrillator. Designed with feedback from more than 200 physicians, the Ellipse offers physicians unique advancements, and is designed to increase patient comfort and physician ease-of-use. Separately, Morgan Stanley upgraded the shares to Overweight this morning, saying it expects the company to benefit from new cardio markets and reduced Durata concerns.